Skip to main content
  1. Ruđer Bošković Institute
  2. News
  3. dm & IRB Mark a Decade of Suppor...

dm & IRB Mark a Decade of Support for Prostate Cancer Research

A €17,290 donation will fund continued research into prostate cancer at the Ruđer Bošković Institute’s Hereditary Cancer Laboratory.
Jan 13th 2026
dm & IRB Mark a Decade of Support for Prostate Cancer Research

On Tuesday, January 13, the drugstore chain dm donated €17,290 to the Ruđer Bošković Institute (RBI). the funds are earmarked for a research project aimed at developing innovative therapies to make prostate cancer more vulnerable and less life-threatening.

This year’s contribution, the largest to date, was raised in collaboration with customers and the Kerempuh Satirical Theatre during the tenth annual Movember campaign. Through this initiative, dm continues to highlight the vital role of preventive care in maintaining men's health.

“If nearly 30 years of corporate social responsibility has taught us anything, it is that progress does not happen overnight,” stated Martina Markota, Head of Corporate Communications at dm. “This is reflected in the milestones we have achieved over a decade of raising awareness about prevention, as well as the breakthroughs RBI scientists have made with our support. Movember is just one example of how dm’s long-term goals and systematic approach can improve public health and foster a culture of proactive prevention.”

Building on last year's progress, where RBI researchers identified three new vulnerabilities in prostate cancer cells, this year’s project aims to investigate whether these "weak spots" can be leveraged to develop more effective targeted medications.

“On behalf of the Ruđer Bošković Institute, I would like to thank dm for their longstanding and consistent support of our prostate cancer research,” said Dr. David M. Smith, Director General of the RBI. “This partnership allows the team at the Hereditary Cancer Laboratory to continue their deep-dive into tumor cells and disease mechanisms. Such work is essential for developing more precise diagnostics and effective treatments for one of the most common cancers among men in Croatia.”

Over the past ten years, dm has supported the research conducted by the Laboratory for Hereditary Cancer (within the RBI’s Division of Molecular Medicine) with nearly €100,000. Beyond driving advancements in therapeutic and diagnostic approaches, this partnership has facilitated the publication of scientific papers, presentations at international conferences, and the completion of several doctoral dissertations and master’s theses.

Contact Us

Public Relations Office

+385 1 457 1269
pr@irb.hr

Više informacija

Petar Ozretić

Head of laboratory
Division of Molecular Medicine
Laboratory for Hereditary Cancer
Petar.Ozretic@irb.hr
Tel:
+385 1 457 1292
Internal phone number:
1849